Study about correlation of anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies with thromboangiitis obliterans

被引:12
|
作者
Guo, Yi [1 ]
Dai, Yuanbin [1 ]
Lai, Junyu [2 ]
Fan, Ying [3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Vasc Surg, Chongqing 400016, Peoples R China
[2] People Hosp Luzhou, Dept Gen Surg, Luzhou, Peoples R China
[3] Second People Hosp Yibin, Dept Gen Surg, Yibin, Sichuan, Peoples R China
关键词
Anti-neutrophil cytoplasmic antibodies (ANCA); anticardiolipid antibodies (ACA); thromboangiitis obliterans (TAO); THROMBOSIS; DISEASE; PATHOGENESIS; RISK; ANCA;
D O I
10.1177/1708538113478742
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Doctors often have difficulties in clinical diagnosis and clinical stage of thromboangiitis obliterans (TAO). Immunolesion was important in the initiation and progression of various kinds of vasculitis diseases, including TAO. Several kinds of immune complexes were developed by immunolesion, including anti-neutrophil cytoplasmic antibodies (ANCA) and anticardiolipin antibodies (ACA). Our aim was to determine if it is an effective way for clinical diagnosis and clinical stage of TAO by detection of the presence of ANCA and ACA in blood serum of patients with TAO and the relationship among the presence of ANCA, ACA and patients with different grades of TAO. Blood samples and clinical characteristics were collected from 38 patients with Rutherford grade I TAO, 30 patients with Rutherford grade II-III TAO, 75 patients with arteriosclerosis obliterans (ASO) and 65 healthy volunteers. Their serum samples were investigated for ANCA by indirect immunofluorescent (IIF), and for ACA and ANCA specificity antigens including reactivity to proteinase 3(PR3), myeloperoxidase (MPO), cathepsin G (CG), bactericidal/permesbility-increasing protein (BPI), elastase (HLE) and lactoferrin (LF) by enzyme linked immunosorbent assay (ELISA). (1) ANCA positive rate and titre were much higher in cases with Rutherford grade I TAO (52.6%, 20/38, 0.386 +/- 0.458) and Rutherford grade II-III TAO (73.3%, 22/30, 0.847 +/- 0.658) than those in cases with ASO (4%, 3/75, 0.011 +/- 0.002) and healthy volunteers (0%,0/65, 0.010 +/- 0.002) (P < 0.01). ANCA positive rate and titre were higher in cases with Rutherford grade II-III TAO (73.3%, 22/30, 0.847 +/- 0.658) than those in cases with Rutherford grade I TAO (52.6%, 20/38, 0.386 +/- 0.458) (P < 0.05). (2) ACA concentration was much higher in cases with Rutherford grade I TAO (270.13 +/- 13.05 IU/mL) and Rutherford grade II-III TAO (279.33 +/- 19.98 IU/mL) than that in cases with ASO (236.85 +/- 17.32 IU/mL) and healthy volunteers (229.16 +/- 15.55 IU/mL) (P < 0.05) respectively. (3) In 42 cases of ANCA-positive samples, there were 20 cases reacted with MPO, 14 cases reacted with LF, five cases reacted with HLE, five cases reacted with BPI and no one reacted with PR3 and CG. All cases were Rutherford grade II-III TAO. Our results indicate that ANCA, ANCA specificity antigens and ACA were detected susceptibly and availably in patients with TAO. Thus, detection of ANCA, ANCA specificity antigens and ACA was helpful for clinical diagnosis of TAO and detection of ANCA and ANCA specificity antigens was helpful for clinical staging of TAO. They are important assistance for clinical diagnosis and stage of TAO.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 50 条
  • [1] Anti-neutrophil cytoplasmic antibodies and their clinical significance
    Supaporn Suwanchote
    Muanpetch Rachayon
    Pongsawat Rodsaward
    Jongkonnee Wongpiyabovorn
    Tawatchai Deekajorndech
    Helen L. Wright
    Steven W. Edwards
    Michael W. Beresford
    Pawinee Rerknimitr
    Direkrit Chiewchengchol
    Clinical Rheumatology, 2018, 37 : 875 - 884
  • [2] Anti-Neutrophil Cytoplasmic Antibodies: To Care or Not to Care
    Shahid, Sara
    Alam, Syed H.
    Gaber, Lillian
    Ahmed, Salman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [3] Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis
    Galperin, C
    Shoenfeld, Y
    Gilburd, B
    Esterre, P
    Meroni, PL
    DelPapa, N
    Halpern, GM
    Andriantsimahavandy, A
    Gershwin, ME
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (05) : 479 - 483
  • [4] Anti-neutrophil cytoplasmic antibodies and their clinical significance
    Suwanchote, Supaporn
    Rachayon, Muanpetch
    Rodsaward, Pongsawat
    Wongpiyabovorn, Jongkonnee
    Deekajorndech, Tawatchai
    Wright, Helen L.
    Edwards, Steven W.
    Beresford, Michael W.
    Rerknimitr, Pawinee
    Chiewchengchol, Direkrit
    CLINICAL RHEUMATOLOGY, 2018, 37 (04) : 875 - 884
  • [5] Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis
    Bornstein, Gil
    Ben-Zvi, Ilan
    Furie, Nadav
    Grossman, Chagai
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (05) : 940 - 945
  • [6] A historical essay on detection of anti-neutrophil cytoplasmic antibodies
    Rasmussen, Niels
    Wiik, Allan
    Jayne, David R.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i8 - i13
  • [7] Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis
    Moxey, Jayne
    Huq, Molla
    Proudman, Susanna
    Sahhar, Joanne
    Ngian, Gene-Siew
    Walker, Jenny
    Strickland, Gemma
    Wilson, Michelle
    Ross, Laura
    Major, Gabor
    Roddy, Janet
    Stevens, Wendy
    Nikpour, Mandana
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [8] ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN LUPUS NEPHRITIS
    Ditto, M.
    Sinico, R. A.
    Trezzi, B.
    Sarzi-Puttini, P.
    Moroni, G.
    Raffiotta, F.
    Messa, P.
    Quaglini, S.
    Radice, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S94 - S95
  • [9] Anti-Cardiolipin and Anti-Neutrophil Cytoplasmic Antibodies in Iranian Patients with Behcet's Disease
    Ataollahi, Mohammad Reza
    Aflaki, Elham
    Nazarinia, Mohammad Ali
    Shenavandeh, Saeedeh
    Habibagahi, Zahra
    Gharesi-Fard, Behrouz
    Kamali-Sarvestani, Eskandar
    IRANIAN JOURNAL OF IMMUNOLOGY, 2012, 9 (04) : 241 - 247
  • [10] Anti-neutrophil cytoplasmic antibodies in primary small vessel vasculitides
    Wiik, AS
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, 25 (02) : 65 - 69